Fezolinetant
CAS: 1629229-37-3
Indication: For the treatment of moderate to severe vasomotor symptoms due to menopause.
CAS: 1629229-37-3
Indication: For the treatment of moderate to severe vasomotor symptoms due to menopause.
Address: RM503, Wanhai Building B, Nanhai Avenue, Nanshan District,Shenzhen 518067 P.R. China.
Tel: (86) 755-82960263 (For All)
Web: www.haorui.com
Email: info@haorui.com
